ISRCTN65939658已完成不适用
Age of Red blood cells In Premature Infants: a multicentre, two arm, randomised parallel trial
Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute0 个研究点目标入组 450 人开始时间: 2006年10月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Requirement of a second allogeneic RBC transfusion for the treatment of prematurity
- •2. Infant age 0 - 27 days, either sex
- •3. Less than 1250 grams birth weight
- •4. Admitted to the participating Neonatal Intensive Care Unit (NICU)
- •5. Parents or guardian have signed (proxy) informed consent
排除标准
- •1. Infants whose first transfusion was older than seven days
- •2. Infants already given a second RBC transfusion
- •3. Infants scheduled to undergo an exchange transfusion
- •4. Infants that will receive directed donations
- •5. Infants that have rare blood types or difficulty with cross-matching
- •6. Infants whose proxy has refused consent
- •7. Infants who are moribund upon admission to the NICU or not expected to survive due to a severe congenital anomaly
研究者
相似试验
已完成
不适用
Age of Red Blood Cells in Premature Infants Study (ARIPI)Premature BirthNCT00326924Ottawa Hospital Research Institute377
已完成
2 期
umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)Retinopathy of PrematurityNCT05100212Fondazione Policlinico Universitario Agostino Gemelli IRCCS146
已完成
2 期
Darbepoetin Administration to Preterm InfantsInfant, NewbornNCT00334737University of New Mexico102
已完成
2 期
Stannsoporfin With Light Therapy for Newborn Babies With JaundiceJaundice, NeonatalHyperbilirubinemia, NeonatalNCT01887327InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company91
已完成
不适用
Blood transfusions for preterm infants and free radicalseonatal diseasesNeonatal DiseasesISRCTN72984863HS R&D Regional Programme Register - Department of Health (UK)